Clinical Trial Update: The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing azithromycin ophthalmic solution 1% to placebo for blepharitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis

Drugs mentioned

• Azithromycin ophthalmic solution 1% (azithromycin ophthalmic solution)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Blepharitis | Phase 2 | Status: COMPLETED